SETBP1 was reported to be highly expressed in a subset of AML [20] and CML patients with blast crisis [23], and promoted leukemogenesis by inhibiting tumor suppressor gene PP2A [31]. Here, PTPA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.